Skip to main content
. 2016 Feb 10;20(6):1118–1127. doi: 10.1111/jcmm.12800

Figure 3.

Figure 3

Silencing TRPV2 and TRPV4 channels with corresponding shRNA. (A) Images of RT‐PCR in cells infected by scrambled shRNA, TRPV2 shRNA or TRPV4 shRNA for 96 hrs in human cardiac c‐kit+ progenitor cells. (B) Relative mean values of mRNA for TRPV2 and TRPV4 in cells infected by corresponding specific shRNAs (n = 3, **P < 0.01 versus scrambled shRNA). (C) Western blots of cells infected by scrambled shRNA, TRPV2 shRNA or TRPV4 shRNA. (D) Relative mean values of TRPV2 and TRPV4 protein in cells infected with corresponding shRNAs (n = 3, **P < 0.01 versus scrambled shRNA). TRPV, transient receptor potential vanilloid.